Somatoparaphrenia

From WikiMD's WELLNESSPEDIA


Somatoparaphrenia
Synonyms
Pronounce N/A
Specialty Neurology, Psychiatry
Symptoms Delusion that a limb or side of the body does not belong to oneself
Complications N/A
Onset
Duration
Types
Causes Brain damage, often involving the right hemisphere
Risks
Diagnosis Clinical assessment, neuroimaging
Differential diagnosis Anosognosia, Body integrity identity disorder
Prevention N/A
Treatment Cognitive therapy, pharmacotherapy
Medication N/A
Prognosis Varies, often chronic
Frequency Rare
Deaths N/A


Somatoparaphrenia is a type of monothematic delusion where one denies ownership of a limb or an entire side of one's body. Even if provided with undeniable proof that the limb belongs to and is connected to their body, the patient produces elaborate confabulations about whose it is or how it got there.

Causes[edit]

Somatoparaphrenia is most commonly observed after a stroke, affecting the right parietal lobe of the brain. This condition is also associated with other neurological disorders such as Alzheimer's disease and migraines.

Symptoms[edit]

The primary symptom of somatoparaphrenia is the denial of ownership of a limb or an entire side of the body. The patient may also experience hallucinations, confabulation, and sometimes neglect of the affected limb.

Diagnosis[edit]

Diagnosis of somatoparaphrenia is primarily based on the patient's symptoms and medical history. Neurological examinations and brain imaging techniques such as MRI and CT scan may also be used to confirm the diagnosis.

Treatment[edit]

Treatment for somatoparaphrenia primarily involves neuropsychological rehabilitation. This includes therapies such as mirror therapy, cognitive behavioral therapy (CBT), and physiotherapy. Medications may also be used to manage symptoms.

See also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.